As of 2025-09-17, the Relative Valuation of Abivax SA (ABVX.PA) is (13.46) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 68.60 EUR, the upside of Abivax SA based on Relative Valuation is -119.6%.
The range of the Relative Valuation is (12.83) - (18.76) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.9x - 6.2x | 3.6x |
| Forward P/E multiples | 4.2x - 7.0x | 5.3x |
| Fair Price | (12.83) - (18.76) | (13.46) |
| Upside | -118.7% - -127.3% | -119.6% |
| Date | P/E |
| 2025-09-08 | -24.89 |
| 2025-09-05 | -25.29 |
| 2025-09-04 | -24.06 |
| 2025-09-03 | -23.64 |
| 2025-09-02 | -22.81 |
| 2025-09-01 | -22.28 |
| 2025-08-29 | -22.71 |
| 2025-08-28 | -22.71 |
| 2025-08-27 | -22.74 |
| 2025-08-26 | -22.35 |
| 2025-08-25 | -21.62 |
| 2025-08-22 | -21.98 |
| 2025-08-21 | -20.63 |
| 2025-08-20 | -19.50 |
| 2025-08-19 | -19.44 |
| 2025-08-18 | -19.73 |
| 2025-08-15 | -19.83 |
| 2025-08-14 | -19.50 |
| 2025-08-13 | -19.73 |
| 2025-08-12 | -19.73 |
| 2025-08-11 | -20.06 |
| 2025-08-08 | -19.97 |
| 2025-08-07 | -20.03 |
| 2025-08-06 | -20.26 |
| 2025-08-05 | -19.83 |
| 2025-08-04 | -20.23 |
| 2025-08-01 | -20.23 |
| 2025-07-31 | -21.16 |
| 2025-07-30 | -20.43 |
| 2025-07-29 | -19.97 |
| 2025-07-28 | -18.84 |
| 2025-07-25 | -18.84 |
| 2025-07-24 | -19.27 |
| 2025-07-23 | -17.95 |
| 2025-07-22 | -2.94 |
| 2025-07-21 | -2.98 |
| 2025-07-18 | -2.85 |
| 2025-07-17 | -2.87 |
| 2025-07-16 | -2.78 |
| 2025-07-15 | -2.62 |
| 2025-07-14 | -2.41 |
| 2025-07-11 | -2.35 |
| 2025-07-10 | -2.33 |
| 2025-07-09 | -2.23 |
| 2025-07-08 | -2.26 |
| 2025-07-07 | -2.25 |
| 2025-07-04 | -2.32 |
| 2025-07-03 | -2.21 |
| 2025-07-02 | -2.27 |
| 2025-07-01 | -2.18 |